Ellipsys Vascular Access System Post Market Surveillance (PS) Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 142 participants.

Also called NCT04484220

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 142 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04484220
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04484220. Allocation not applicable; no masking; primary purpose other. Start 2021-04-13 (actual); primary completion 2025-03-31 (actual). Results posted on 2026-05-07.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ellipsys Vascular Access System Post Market Surveillance (PS) Study
Condition
Renal Disease, End Stage
Condition
Kidney Disease, End-Stage
Condition
AV Fistula
Condition
Fistulas Arteriovenous
Intervention (Device)
Ellipsys Vascular Access System
Lead sponsor
Medtronic Endovascular (class: industry)

Record details

Record id
cardio:ct-nct04484220
Content hash
903fcd5b72b21d053da75a32cc3e0511799361e4707c4c8aa315159fbaa6e20f